Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
C$1.00 0.00 (0.00%)
As of 04:00 PM Eastern

TLRY vs. BHC, AUP, CARA, CRON, TEV, ABT, NOT, PYR, SLS, and NVO

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Solaris Resources (SLS), and Novo Resources Corp. (NVO.V) (NVO). These companies are all part of the "pharmaceutical products" industry.

Tilray Brands vs.

Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Bausch Health Companies received 39 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 63.93% of users gave Bausch Health Companies an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%
Bausch Health CompaniesOutperform Votes
39
63.93%
Underperform Votes
22
36.07%

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$610.34M1.06-C$183.24M-C$0.41-2.42
Bausch Health CompaniesC$6.69B0.39-C$125.65M-C$0.68-14.85

11.2% of Tilray Brands shares are held by institutional investors. Comparatively, 79.0% of Bausch Health Companies shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Tilray Brands has a beta of 2.19, indicating that its share price is 119% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bausch Health Companies has a net margin of -1.88% compared to Tilray Brands' net margin of -30.02%. Bausch Health Companies' return on equity of 15.87% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-30.02% -7.24% -1.41%
Bausch Health Companies -1.88%15.87%4.16%

In the previous week, Tilray Brands had 2 more articles in the media than Bausch Health Companies. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 0.00 beat Tilray Brands' score of -0.31 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company Overall Sentiment
Tilray Brands Neutral
Bausch Health Companies Neutral

Summary

Bausch Health Companies beats Tilray Brands on 11 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$644.37MC$2.40BC$5.79BC$5.58B
Dividend YieldN/A2.92%4.76%6.49%
P/E Ratio-2.424.2924.8929.81
Price / Sales1.06722.81373.97439.82
Price / Cash5.9510.2538.0582.94
Price / Book0.257.337.333.50
Net Income-C$183.24MC$20.70BC$3.18BC$298.86M
7 Day Performance-13.79%-1.20%-3.31%-2.47%
1 Month Performance-31.03%0.96%-7.14%-2.40%
1 Year Performance-56.33%97.56%12.21%29.87%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
N/AC$1.00
flat
N/A-57.6%C$644.37MC$610.34M-2.422,650Gap Down
BHC
Bausch Health Companies
N/AC$10.23
-1.7%
N/A-22.5%C$2.66BC$6.69B-14.9719,900
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300News Coverage
High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
CRON
Cronos Group
0.5006 of 5 stars
C$2.73
-1.8%
C$3.54
+29.7%
+3.3%C$720.90MC$76.86M-15.19450News Coverage
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
SLS
Solaris Resources
1.3605 of 5 stars
C$5.05
-2.5%
C$13.50
+167.3%
+11.8%C$579.31MN/A-8.8010News Coverage
Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400

Related Companies and Tools


This page (TSE:TLRY) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners